0000899243-20-002868.txt : 20200204
0000899243-20-002868.hdr.sgml : 20200204
20200204180204
ACCESSION NUMBER: 0000899243-20-002868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200131
FILED AS OF DATE: 20200204
DATE AS OF CHANGE: 20200204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sorensen Mel
CENTRAL INDEX KEY: 0001444783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 20575292
MAIL ADDRESS:
STREET 1: 7 RAPPS RUN DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-31
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001444783
Sorensen Mel
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
1
1
0
0
President and CEO
Stock Option (Right to Buy)
14.84
2020-01-31
4
A
0
186087
0.00
A
2030-01-30
Common Stock
186087
186087
D
The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 31, 2020.
/s/ J. Mel Sorensen
2020-02-04